Trials / Withdrawn
WithdrawnNCT01903486
Assessing the Efficacy of Steroid Treatment of Achalasia
A Pilot Study Assessing the Efficacy of Steroids in the Treatment of Achalasia
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Would systemic steroids be an effective treatment in early variants of achalasia?
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Apo-Prednisone Cordorol, Detasone - Prednisone | Oral prednisone (study medication) at a dose of 40mg for 1 week, then 30mg for 1 week, then 20mg for 1 week, then 10mg for 1 week, and then stop the medication. |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2020-12-28
- Completion
- 2020-12-28
- First posted
- 2013-07-19
- Last updated
- 2021-11-17
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT01903486. Inclusion in this directory is not an endorsement.